Correlation Between CellaVision and Devyser Diagnostics

Can any of the company-specific risk be diversified away by investing in both CellaVision and Devyser Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CellaVision and Devyser Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CellaVision AB and Devyser Diagnostics AB, you can compare the effects of market volatilities on CellaVision and Devyser Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CellaVision with a short position of Devyser Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CellaVision and Devyser Diagnostics.

Diversification Opportunities for CellaVision and Devyser Diagnostics

0.3

Correlation Coefficient

CellaVision  Devyser Diagnostics

Weak diversification

The 3 months correlation between CellaVision and Devyser is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding CellaVision AB and Devyser Diagnostics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Devyser Diagnostics and CellaVision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CellaVision AB are associated (or correlated) with Devyser Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Devyser Diagnostics has no effect on the direction of CellaVision i.e., CellaVision and Devyser Diagnostics go up and down completely randomly.

Pair Corralation between CellaVision and Devyser Diagnostics

Assuming the 90 days trading horizon CellaVision is expected to generate 2.8 times less return on investment than Devyser Diagnostics. In addition to that, CellaVision is 1.47 times more volatile than Devyser Diagnostics AB. It trades about 0.05 of its total potential returns per unit of risk. Devyser Diagnostics AB is currently generating about 0.23 per unit of volatility. If you would invest  9,700  in Devyser Diagnostics AB on April 23, 2025 and sell it today you would earn a total of  3,500  from holding Devyser Diagnostics AB or generate 36.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CellaVision AB  vs.  Devyser Diagnostics AB

CellaVision AB

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CellaVision AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CellaVision may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Devyser Diagnostics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Devyser Diagnostics AB are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Devyser Diagnostics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CellaVision and Devyser Diagnostics

The main advantage of trading using opposite CellaVision and Devyser Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CellaVision position performs unexpectedly, Devyser Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Devyser Diagnostics will offset losses from the drop in Devyser Diagnostics' long position.

The idea behind CellaVision AB and Devyser Diagnostics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.